Haemopharm is a company belonging to the Paolo Gobbi Frattini S.r.l. group, which manufactures flexible PVC and PVC-free bags (EVA bags, Polyurethane bags, multilayer bags, multilayer PVC-free bags) since more than 40 years.
Haemopharm manufactures CE marked medical devices for different therapeutic areas with a special focus on drug delivery: biotechnology, oncology, Infusion therapy with antibiotics, clinical nutrition (enteral nutrition and TPN), pharmacy compounding, drug reconstitution, blood and cell therapies, regenerative therapies, ophthalmology, ozone therapy.
Thanks to its proprietary technology, Haemopharm products are customizable, available in different configurations and as standard, double chamber, or multichamber bags and can be sterilized by EtO, gamma rays, beta rays or produced in isolator.
Haemopharm can also offer a wide range of components, including last generation needlefree valves and solutions manufactured asepetically into isolator such as liquids for the preservation of the corneal tissues.
The group also includes Quatalia Science d.d.o. a subsidiary of LU scientific d.d.o. based in Belgrade (Serbia) mainly focused on the pharmaceutical sector, St. Agatha S.r.l. Clinical Division and the contractual Joint venture Advatis with Siad Healthcare which operates in the life science sector.
Haemopharm keeps expanding its market globally and strongly invests in R&D and has developed more than 20 international patents and trademarks.

CPhI 2012 Winner